Deutsches Krebsforschungszentrum (DKFZ)

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) () Cossarizza A, Acs A, Adam D, Adam-Klages S, Agace WW, Aghaeepour N, Akdis M, et al. Journal article Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer (2025) Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, et al. Journal article AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment (2025) Lorenz NI, Sauer B, Urban H, Weinem JB, Parmar BS, Zeiner PS, Strecker MI, et al. Journal article Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial (2025) Gani C, Fokas E, Polat B, Ott O, Diefenhardt M, Königsrainer A, Böke S, et al. Journal article First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG (2025) Reinhard S, Utikal JS, Zaremba A, Lodde G, von Wasielewski I, Klespe KC, Meier F, et al. Journal article Correction: The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (Journal of Cancer Research and Clinical Oncology, (2025), 151, 1, (30), 10.1007/s00432-024-06063-z) (2025) Roohani S, Handtke J, Hummedah K, Albertsmeier M, Andreou D, Apostolidis L, Augustin M, et al. Journal article, Erratum Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnostics (2025) Ritter M, Blume C, Tang Y, Patel A, Patel B, Berghaus N, Kada Benotmane J, et al. Journal article Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing (2025) Tetzlaff SK, Reyhan E, Layer N, Bengtson CP, Heuer A, Schroers J, Faymonville AJ, et al. Journal article Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis. (2025) Diehl C, Soberón V, Baygün S, Chu Y, Mandelbaum J, Kraus L, Engleitner T, et al. Journal article Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma (2025) Reitmajer M, Livingstone E, Thoms KM, Heppt M, Meiss F, Gesierich A, Drexler K, et al. Journal article